7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Residential Address Amplifies Health Disparities and Risk of Infection in Individuals With Diabetic Foot Ulcers

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          OBJECTIVE

          To determine the association between social determinants of health (SDOH) and a diagnosis of diabetic foot ulcer (DFU) infection.

          RESEARCH DESIGN AND METHODS

          Targeted interrogation of electronic health record data using novel search engines to analyze individuals with a DFU infection during a 5-year period (2013–2017) was performed. We extracted geolocated neighborhood data and SDOH characteristics from the National Neighborhood Data Archive and used univariate and multiple logistic regression to evaluate associations with outcomes in the population with diabetes.

          RESULTS

          Among 4.3 million people overall and 144,564 individuals with diabetes seen between 2013 and 2017, 8,351 developed DFU, of which cases 2,252 were complicated by a DFU infection. Sex interactions occurred, as men who experienced a DFU infection more frequently identified as having nonmarried status than their female counterparts. For the population with DFU infection, there were higher rates for other SDOH, including higher neighborhood disadvantaged index score, poverty, nonmarriage, and less access to physician/allied health professionals (all P < 0.01). In multiple logistic regression, those individuals who developed DFU infection came from neighborhoods with greater Hispanic and/or foreign-born concentrations (odds ratio 1.11, P = 0.015).

          CONCLUSIONS

          We found significant differences in neighborhood characteristics driving a higher risk for DFU infection in comparisons with the grouping of individuals with diabetes overall, including increased risk for individuals with Hispanic and/or foreign-born immigration status. These data strongly support the need to incorporate SDOH, particularly ethnic and immigration status, into triage algorithms for DFU risk stratification to prevent severe diabetic foot complications and move beyond biologic-only determinants of health.

          Graphical Abstract

          Related collections

          Most cited references38

          • Record: found
          • Abstract: not found
          • Article: not found

          Diabetic Foot Ulcers and Their Recurrence.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis †.

            Diabetic foot is a severe public health issue, yet rare studies investigated its global epidemiology. Here we performed a systematic review and meta-analysis through searching PubMed, EMBASE, ISI Web of science, and Cochrane database. We found that that global diabetic foot ulcer prevalence was 6.3% (95%CI: 5.4-7.3%), which was higher in males (4.5%, 95%CI: 3.7-5.2%) than in females (3.5%, 95%CI: 2.8-4.2%), and higher in type 2 diabetic patients (6.4%, 95%CI: 4.6-8.1%) than in type 1 diabetics (5.5%, 95%CI: 3.2-7.7%). North America had the highest prevalence (13.0%, 95%CI: 10.0-15.9%), Oceania had the lowest (3.0%, 95% CI: 0.9-5.0%), and the prevalence in Asia, Europe, and Africa were 5.5% (95%CI: 4.6-6.4%), 5.1% (95%CI: 4.1-6.0%), and 7.2% (95%CI: 5.1-9.3%), respectively. Australia has the lowest (1.5%, 95%CI: 0.7-2.4%) and Belgium has the highest prevalence (16.6%, 95%CI: 10.7-22.4%), followed by Canada (14.8%, 95%CI: 9.4-20.1%) and USA (13.0%, 95%CI: 8.3-17.7%). The patients with diabetic foot ulcer were older, had a lower body mass index, longer diabetic duration, and had more hypertension, diabetic retinopathy, and smoking history than patients without diabetic foot ulceration. Our results provide suggestions for policy makers in deciding preventing strategy of diabetic foot ulceration in the future. Key messages Global prevalence of diabetic foot is 6.3% (95%CI: 5.4-7.3%), and the prevalence in North America, Asia, Europe, Africa and Oceania was 13.0% (95%CI: 10.0-15.9%), 5.5% (95%CI: 4.6-6.4%), 5.1% (95%CI: 4.1-6.0%), 7.2% (95%CI: 5.1-9.3%), and 3.0% (95% CI: 0.9-5.0%). Diabetic foot was more prevalent in males than in females, and more prevalent in type 2 diabetic foot patients than in type 1 diabetic foot patients. The patients with diabetic foot were older, had a lower body mass index, longer diabetic duration, and had more hypertension, diabetic retinopathy, and smoking history than patients without diabetic foot.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The global burden of diabetic foot disease.

              Diabetic foot problems are common throughout the world, resulting in major economic consequences for the patients, their families, and society. Foot ulcers are more likely to be of neuropathic origin, and therefore eminently preventable, in developing countries, which will experience the greatest rise in the prevalence of type 2 diabetes in the next 20 years. People at greatest risk of ulceration can easily be identified by careful clinical examination of the feet: education and frequent follow-up is indicated for these patients. When assessing the economic effects of diabetic foot disease, it is important to remember that rates of recurrence of foot ulcers are very high, being greater than 50% after 3 years. Costing should therefore include not only the immediate ulcer episode, but also social services, home care, and subsequent ulcer episodes. A broader view of total resource use should include some estimate of quality of life and the final outcome. An integrated care approach with regular screening and education of patients at risk requires low expenditure and has the potential to reduce the cost of health care.
                Bookmark

                Author and article information

                Journal
                Diabetes Care
                Diabetes Care
                diabetes care
                Diabetes Care
                American Diabetes Association
                0149-5992
                1935-5548
                March 2024
                19 January 2024
                19 January 2024
                : 47
                : 3
                : 508-515
                Affiliations
                [1 ]Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Health, Ann Arbor, MI
                [2 ]Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI
                [3 ]Division of Cardiology, Department of Medicine, University of Michigan Health, University of Michigan Medical School, Ann Arbor, MI
                Author notes
                Corresponding author: Brian M. Schmidt, bmcs@ 123456med.umich.edu
                Author information
                https://orcid.org/0000-0002-2561-9243
                https://orcid.org/0000-0002-2042-1350
                Article
                231787
                10.2337/dc23-1787
                10909679
                38241187
                044b3b63-2de2-43d1-b72c-6c0e39cbe1fd
                © 2024 by the American Diabetes Association

                Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.

                History
                : 22 September 2023
                : 28 December 2023
                Funding
                Funded by: Division of Diabetes, Endocrinology, and Metabolic Diseases, DOI 10.13039/100017618;
                Award ID: K23DK131261
                Award ID: R01DK107956
                Award ID: R01DK11672
                Award ID: U01DK119083
                Funded by: JDRF, DOI 10.13039/100022690;
                Award ID: University of Michigan
                This work was supported as follows: B.M.S. is principal investigator (PI) on National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant K23DK131261 and co-investigator on NIDDK grant U01DK119083. R.P.-B. is PI on NIDDK grants R01DK107956, R01DK11672, and U01DK119083 and is supported by the JDRF Center of Excellence at UM. S.S.H. is supported by National Heart, Lung, and Blood Institute grants RO1HL53384 and NIDDK R01DK128012.
                Categories
                Original Article

                Endocrinology & Diabetes
                Endocrinology & Diabetes

                Comments

                Comment on this article